Dr. Laura Indolfi is the Founder & CEO of PanTher Therapeutics, a clinical stage oncology company, spin-out from Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital (MGH), revolutionizing cancer care by harnessing sustained treatments engineered for localized applications. At PanTher, she is bringing the fight against cancer precisely to the target with the proprietary treatment platform, Sagittari™, designed to enhance therapeutic response with minimal side effects.
Dr. indolfi's scientific expertise covers a broad range of therapeutic areas (cardio, cancer, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, she has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business schools, combining the science and business knowledge to drive the company’s vision. Prior to PanTher, she was a research associate at the Harvard-MIT Institute for Medical Engineering and Science and served as an entrepreneur-in-residence at the MGH Cancer Center.
Dr. Indolfi strongly believes in the power of outreaching initiatives to promote research awareness and foster the public audiences’ discovery of the beauty of science. In 2014 the line of clothes Cytocouture, created in collaboration with Colombian designer Carlos Villamil and inspired by her cell-therapy research, won the global competition Descience. In 2016, she was named a TED Fellow, one of 21 people chosen annually by the TED organization who are considered to be the most disruptive and transformative change-makers in the world. In 2017, she attended the prestigious conference “Fortune: Most Powerful Women – Next Gen”, an invite-only summit hosted by Fortune gathering a stellar group of game-changing executives, entrepreneurs and innovators in business. Dr. Indolfi is also one of the five women who were selected by Massachusetts Life Science Center and Takeda for their inaugural class in 2018 of MassNextGen program, honoring exceptional leaders in the biotech industry. Since January 2020 she serves on the Advisory Board of WEST – Women in the Enterprise of Science and Technology and is a Founding Member of the CHIEF Boston chapter.
Sessions: